Skip to main content
. 2019 Feb 21;316(5):R512–R524. doi: 10.1152/ajpregu.00345.2018

Table 2.

Disease-specific characteristics and medications

HFrEF (n = 8)
Disease-specific characteristics
 Left ventricular ejection fraction, % (mean ± SE) 30 ± 3
 Diagnosis
    Ischemic 6/8
    Nonischemic 2/8
 NYHA class
    II 4/8
    III 4/8
 Diabetic 4/8
Medications
 β-Blocker 8/8
 ACE inhibitor 6/8
 Angiotensin receptor inhibitor 2/8
 Statin 7/8
 Diuretic 8/8
 Aldosterone inhibitor 2/8
 Digoxin 1/8
 Anticoagulant 7/8

n = number of subjects. HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association; ACE, angiotensin-converting enzyme.